Brief: China Biotech Services Holdings Ltd Sees A Net Profit Of Not Less Than HK$26 Million For Q1
03/05/2021 11:25
May 3 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* SEES A NET PROFIT OF NOT LESS THAN HK$26 MILLION FOR 2021
Q1
* EXPECTED RESULT DUE TO INCREASE IN REVENUE FROM MEDICAL
LABORATORY TESTING AND HEALTH CHECK SERVICES SEGMENT
Source text for Eikon: ID:nHKS8dY2Qm
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)